Bay Colony Advisory Group, Inc D Pacific Biosciences Of California, Inc. Transaction History

Bay Colony Advisory Group, Inc D

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$5.97 - $10.36 $4,179 - $7,252	-700 Reduced 2.67%	25,526 $250,000
Q3 2023 Nov 13, 2023	SELL	$8.23 - $13.93 $10,904 - $18,457	-1,325 Reduced 4.81%	26,226 $218,000
Q2 2023 Aug 11, 2023	SELL	$9.97 - $14.05 $44,865 - $63,225	-4,500 Reduced 14.04%	27,551 $366,000
Q1 2023 Apr 27, 2023	BUY	$7.94 - $12.02 $9,925 - $15,025	1,250 Added 4.06%	32,051 $371,000
Q4 2022 Feb 01, 2023	BUY	$5.67 - $11.2 $7,087 - $14,000	1,250 Added 4.23%	30,801 $251,000
Q3 2022 Oct 27, 2022	BUY	$3.93 - $8.57 $48,928 - $106,696	12,450 Added 72.8%	29,551 $172,000
Q2 2022 Aug 08, 2022	BUY	$4.02 - $10.43 $9,434 - $24,479	2,347 Added 15.91%	17,101 $75,000
Q1 2022 Apr 28, 2022	BUY	$8.43 - $20.9 $851 - $2,110	101 Added 0.69%	14,754 $134,000
Q4 2021 Jan 28, 2022	BUY	$19.26 - $30.08 $2,889 - $4,512	150 Added 1.03%	14,653 $300,000
Q3 2021 Nov 02, 2021	BUY	$24.86 - $35.02 $44,126 - $62,160	1,775 Added 13.95%	14,503 $371,000
Q2 2021 Jul 22, 2021	BUY	$22.3 - $36.02 $18,397 - $29,716	825 Added 6.93%	12,728 $445,000
Q1 2021 May 13, 2021	BUY	$26.38 - $51.15 $314,001 - $608,838	11,903 New	11,903 $396,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.